HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Large plaque parapsoriasis: clinical and genotypic correlations.

Abstract
Twelve patients with large plaque parapsoriasis (LPP) were investigated for the presence of predominant T-cell clones, analyzing the T-cell receptor (TCR) gamma-chain gene. The diagnostic and prognostic significance of TCR gene rearrangement status was assessed by a correlation with the long-term clinical follow-up. Six out of 12 patients showed a clonal T-cell population. Clinically, among the patients with clonal disease one developed clearcut mycosis fungoides (MF) after a follow-up of 8 years, in the other 5 patients no such diagnosis could be made after follow-up of 2-21 years (median: 9 years). In patients with polyclonal infiltrates the lesions remained virtually unchanged. These findings indicate that in LPP TCR gene rearrangement status has no prognostic significance and does not allow distinction of LPP and early MF. Both conditions show a clonal T-cell infiltrate with similar frequency, are very similar in clinical and histologic presentation and according to recent studies share the same low risk to develop overt MF. Therefore both terms refer to the identical clinical situation. This should be designated as early MF and efforts should concentrate on identifying those patients that are at risk to develop aggressive disease.
AuthorsM Simon, M J Flaig, P Kind, C A Sander, P Kaudewitz
JournalJournal of cutaneous pathology (J Cutan Pathol) Vol. 27 Issue 2 Pg. 57-60 (Feb 2000) ISSN: 0303-6987 [Print] United States
PMID10678699 (Publication Type: Journal Article)
Chemical References
  • Receptors, Antigen, T-Cell, gamma-delta
Topics
  • Adult
  • Aged
  • Alleles
  • Biopsy
  • Follow-Up Studies
  • Gene Rearrangement
  • Genotype
  • Humans
  • Middle Aged
  • Mycosis Fungoides (genetics, pathology)
  • Parapsoriasis (genetics, pathology)
  • Receptors, Antigen, T-Cell, gamma-delta (genetics)
  • Skin (pathology)
  • Skin Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: